Related Experiment Video
Updated: Jan 1, 2026

08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.6K
NFIL3 Acts as a Nuclear Factor to Increase Osteosarcoma Progression
Jiaxing Xu1, Gongping Xu2, Tingxin Zhang2
1Department of Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin 150000, China.
Biomed Research International
|December 31, 2019
Summary
Nuclear factor interleukin 3 (NFIL3) promotes osteosarcoma progression. This study found NFIL3 is highly expressed in osteosarcoma tissues and drives cancer cell proliferation, migration, and invasion.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma is an aggressive bone cancer with poorly understood progression mechanisms.
- Identifying key factors in osteosarcoma proliferation, migration, and invasion is crucial for developing new treatments.
Purpose of the Study:
- To investigate the role of Nuclear factor interleukin 3 (NFIL3) in osteosarcoma progression.
- To determine if NFIL3 expression correlates with osteosarcoma aggressiveness.
Main Methods:
- Analyzed NFIL3 expression in osteosarcoma tissues using RT-PCR and immunohistochemistry.
- Assessed NFIL3's impact on osteosarcoma cell proliferation via growth and colony formation assays.
- Evaluated NFIL3's effect on cell migration and invasion using wound healing and transwell assays.
Main Results:
- NFIL3 was found to be overexpressed in 15 out of 20 osteosarcoma tissue samples.
- In vitro studies demonstrated that NFIL3 significantly promoted osteosarcoma cell proliferation (P < 0.01).
- NFIL3 also significantly enhanced osteosarcoma cell migration and invasion (P < 0.05).
Conclusions:
- High NFIL3 expression in osteosarcoma tissues correlates with increased cancer cell proliferation, migration, and invasion.
- NFIL3 represents a potential therapeutic target for novel osteosarcoma treatment strategies.
Related Concept Videos
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
The Nucleolus
10.1K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.1K
mTOR Signaling and Cancer Progression
4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.5K
Regulation of Nuclear Protein Sorting
3.1K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.1K

